Navigation Links
HealthMedia(R) Explosive Growth Continues in First Quarter 2008
Date:5/5/2008

ANN ARBOR, Mich., May 5 /PRNewswire/ -- HealthMedia(R), the global leader in scalable behavior change interventions with outcomes, once again reported significant growth -- doubling its first quarter earnings year over year. Healthcare license revenues increased 60 percent and revenue from partnerships with strategic vendors increased 100 percent from first quarter 2007. One new program contributing to this growth was launched in January and serves a large Medicare population. Industry embracement of HealthMedia's Overcoming Insomnia program is also contributing to company growth, with three of the nation's top ten health plans and several large employer groups rolling out the program to more than 14 million covered lives.

To serve its growing customer base and help customers better meet their goals of improving the health of their populations, HealthMedia also announced several new enhancements to its product offerings. Recent updates combine new features and functionality with an investment in infrastructure to ensure smooth operations as product usage continues to grow.

"We are listening to our customers and working hard to improve both their own outcomes and the overall experience for the end users," said Ted Dacko, HealthMedia President and CEO. "From our Fusion technology to our commitment to fill industry gaps for issues such as insomnia, depression, and pain -- among the top drivers of productivity impairment and healthcare costs -- we believe our latest product improvements are yet another important step in fulfilling our strategy."

MyHealthMedia Redesign Includes New Interface

HealthMedia has redesigned the public and private user home pages with a more "Apple(R)-like" interface. "This is the beginning of an 18-month initiative to take the user experience to a whole different level, and enable HealthMedia to protect its already market-leading series of wellness, disease management, and behavioral health solutions," Dacko
'/>"/>

SOURCE HealthMedia, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Targets Found That Stop Tumor Growth
2. Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
3. Researchers identify new cell targets for preventing growth of breast and other tumors
4. A stem cell type supposed to be crucial for angiogenesis and cancer growth does not exist?
5. HealthEdge Receives $13 Million Investment Commitment to Fund Significant Growth
6. Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
7. Growth Hormone is Used to Treat Twice as Many Short Boys Than Girls in the U.S. and Asia; Gender Difference is Smaller in the Rest of the World
8. Growth hormone is used to treat twice as many short boys than girls in the US and Asia
9. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
10. Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find
11. Greenway Medical Technologies Experiences Continued Growth in OB/GYN Marketplace
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Vivakor Announces New Acquisition Strategy 2Millstone Medical Outsourcing Appoints New Leadership of Memphis Facility 2Grapes and Grape Products Show Exciting Potential in Optimizing Health 56833 1Grapes and Grape Products Show Exciting Potential in Optimizing Health 56833 2Grapes and Grape Products Show Exciting Potential in Optimizing Health 56833 3Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research 28ASBMR 29 Meeting 4964 1Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research 28ASBMR 29 Meeting 4964 2Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research 28ASBMR 29 Meeting 4964 3Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research 28ASBMR 29 Meeting 4964 4Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research 28ASBMR 29 Meeting 4964 5Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research 28ASBMR 29 Meeting 4964 6Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research 28ASBMR 29 Meeting 4964 7Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research 28ASBMR 29 Meeting 4964 8Polaroid 28R 29 Continuing Tradition of Support for Boston Marathon 28R 29 Jimmy Fund 28R 29 Walk 56830 1Polaroid 28R 29 Continuing Tradition of Support for Boston Marathon 28R 29 Jimmy Fund 28R 29 Walk 56830 2